Cullinan Therapeutics, Inc.
Extracted from this filing and checked against the source text.
Cullinan Therapeutics, Inc. shareholders approved Ratification of Appointment of KPMG LLP as Independent Registered Public Accounting Firm at the 2026-06-16 meeting.
The Company's stockholders ratified the appointment of KPMG LLP as the Company's independent registered accounting firm for the fiscal year ending December 31, 2026 by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 53,722,477 36,815 3,138 0View on SEC.gov
Cullinan Therapeutics, Inc. shareholders approved Election of Class III Directors at the 2026-06-16 meeting.
The Company's stockholders elected two Class III directors to the Company's Board of Directors for three-year terms or until his successor has been duly elected and qualified, or until his earlier death, resignation or removal, by the following votes: Nominee Votes For Votes Withheld Broker Non-Votes Nadim Ahmed 37,519,241 12,116,759 4,126,430 Stephen Webster 36,963,086 12,672,914 4,126,430View on SEC.gov
Cullinan Therapeutics, Inc. shareholders approved Advisory Vote on Executive Compensation at the 2026-06-16 meeting.
The Company's stockholders approved the advisory vote on the compensation of the Company's named executive officers by the following votes: Votes For Votes Against Abstentions Broker Non-Votes 48,536,734 1,092,209 7,057 4,126,430View on SEC.gov
1639 shareholder votes filed in the last 30 days. Browse all shareholder votes →
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.